pseudobulbar affect (PBA)
Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
The FDA has approved Nuedexta, a medication that treats uncontrolled expression of emotion related to amyotrophic lateral sclerosis
Posted on Monday, November 1, 2010 - 16:09, By: Margaret Wahl
The U.S. Food and Drug Administration (FDA) has approved Nuedexta for "pseudobulbar affect" (PBA), a neurologic condition that sometimes occurs in people with amyotrophic lateral sclerosis (ALS) and involves episodes of involuntary emotional expression out of proportion to or distinct from the...
Avanir's experimental drug Zenvia appears safe and effective for involuntary emotional expression in ALS
Posted on Sunday, August 16, 2009 - 10:18, By: ALSN Staff
The pharamaceutical company Avanir has announced positive results for its phase 3 trial to treat unwanted episodes of laughing and crying in patients with ALS and multiple sclerosis using its experimental drug Zenvia.